Esco Aster

Singapore, SG
Cell Therapy Exosome
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Esco Aster

Signal Score
63.0/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Singapore, SG
Modalities
Cell Therapy, Exosome
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Esco Aster

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy, Exosome
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: Esco Group
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Esco Group
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Singapore, SG
Modalities: Cell Therapy, Exosome
Capacity assessment: 58.0/100
Sites: Singapore, SG
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Singapore, SG
Modalities: Cell Therapy, Exosome
Capacity assessment: 58.0/100

Frequently Asked Questions About Esco Aster

What is Esco Aster's CDMO Signal Score?
Esco Aster has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Esco Aster for a manufacturing program?
Use the free AI matchmaker to compare Esco Aster against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs → Exosome CDMOs →

Similar CDMOs

Cellipont Bioservices
The Woodlands, TX
Cell Therapy, CAR-T, MSC, iPSC, Exosome, Autologous, Allogeneic
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.8
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 83.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody